Recent studies discuss the link between climate change and violent conflict, especially for East Africa. While there is extensive literature on the question whether climate change increase the risk of …
Background: The World Health Organization recommends that treatment of tuberculosis (TB) in HIV-infected patients should be integrated with HIV care. In December 2008, a separate outdoor-integrated TB/HIV clinic was instituted …
The purpose of this study was to determine if using EMDR therapy to treat a married partnerâs trauma would improve marital satisfaction. The project utilized an n-of-1 single case study …
We evaluated the efficacy of oral glutamine supplementation inchildren 2 to 60 months of age with persistent diarrhea by 1:1 randomiza-tion to standard treatment alone or together with twice daily …
Background and Objectives: This study describes a novel global health point-of-care ultrasound (POCUS) curricular education intervention. Often, it is difficult to determine a curriculum that meets the needs of learners …
The international community has come together in new ways to address forced displacementâone of the biggest challenges of the early twenty-first century. A series of high-level events in 2016 acknowledged …
The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the likelihood of neuromuscular respiratory failure, autonomic dysfunction, and other life-threatening symptoms. Currently, very little is known about the underlying …
Objectives: Intravesical Bacillus Calmette-Guerin (BCG) vaccine is the mainstay of treatment and prophylaxis in superficial bladder cancer (SBC) as it reduces tumor recurrence and disease progression. About one-third of patients …
Background: Little is known about the incidence of virological failure among Human Immunodeficiency virus (HIV) infected adults after Uganda transitioned from Zidovidine/Lamivudine/Nevirapine (AZT/3TC/NVP) to Tenofovir/Lamivudine/Efavirenze (TDF/3 T/EFV) as a first-line …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …